BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26956880)

  • 1. Reproductive and genital health and risk of cervical human papillomavirus infection: results from the Ludwig-McGill cohort study.
    Shaw E; Ramanakumar AV; El-Zein M; Silva FR; Galan L; Baggio ML; Villa LL; Franco EL;
    BMC Infect Dis; 2016 Mar; 16():116. PubMed ID: 26956880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group.
    Franco E; Villa L; Rohan T; Ferenczy A; Petzl-Erler M; Matlashewski G
    Rev Panam Salud Publica; 1999 Oct; 6(4):223-33. PubMed ID: 10572472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies.
    Castellsagué X; Díaz M; Vaccarella S; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Meijer CJ; Bosch FX
    Lancet Oncol; 2011 Oct; 12(11):1023-31. PubMed ID: 21917519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk human papillomavirus infection and abnormal cervical cytology among Nepali and Bhutanese refugee women living in eastern Nepal.
    Bhatta MP; Johnson DC; Lama M; Aryal S; Lhaki P; Shrestha S
    BMC Infect Dis; 2017 Jan; 17(1):73. PubMed ID: 28088173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and determinants of high-risk human papillomavirus infection in women from a sub-Saharan African community.
    Sangwa-Lugoma G; Ramanakumar AV; Mahmud S; Liaras J; Kayembe PK; Tozin RR; Lorincz A; Franco EL
    Sex Transm Dis; 2011 Apr; 38(4):308-15. PubMed ID: 21150817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical Infection with Cutaneous Beta and Mucosal Alpha Papillomaviruses.
    Sichero L; El-Zein M; Nunes EM; Ferreira S; Franco EL; Villa LL;
    Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1312-1320. PubMed ID: 28377417
    [No Abstract]   [Full Text] [Related]  

  • 8. Genital tract infection with Chlamydia trachomatis in women attended at a cervical cancer screening program in Northeastern from Brazil.
    Magalhães PA; Miranda CA; Lima ÉG; Moizéis RN; de Lima DB; Cobucci RN; de Medeiros Fernandes TA; de Azevedo JC; de Azevedo PR; de Araújo JM; Fernandes JV
    Arch Gynecol Obstet; 2015 May; 291(5):1095-102. PubMed ID: 25326872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study.
    Thomas JO; Herrero R; Omigbodun AA; Ojemakinde K; Ajayi IO; Fawole A; Oladepo O; Smith JS; Arslan A; Muñoz N; Snijders PJ; Meijer CJ; Franceschi S
    Br J Cancer; 2004 Feb; 90(3):638-45. PubMed ID: 14760378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central Italy.
    Sammarco ML; Del Riccio I; Tamburro M; Grasso GM; Ripabelli G
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):222-6. PubMed ID: 23395560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys.
    Vaccarella S; Herrero R; Dai M; Snijders PJ; Meijer CJ; Thomas JO; Hoang Anh PT; Ferreccio C; Matos E; Posso H; de Sanjosé S; Shin HR; Sukvirach S; Lazcano-Ponce E; Ronco G; Rajkumar R; Qiao YL; Muñoz N; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2148-53. PubMed ID: 17119039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.
    Shields TS; Brinton LA; Burk RD; Wang SS; Weinstein SJ; Ziegler RG; Studentsov YY; McAdams M; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1574-82. PubMed ID: 15466972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
    Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types?
    Kjaer SK; van den Brule AJ; Bock JE; Poll PA; Engholm G; Sherman ME; Walboomers JM; Meijer CJ
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):799-805. PubMed ID: 9332762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015.
    Balanda M; Quiero A; Vergara N; Espinoza G; Martín HS; Rojas G; Ramírez E
    Med Microbiol Immunol; 2016 Dec; 205(6):585-594. PubMed ID: 27539577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus prevalence and type distribution among women attending routine gynecological examinations in Saudi Arabia.
    AlObaid A; Al-Badawi IA; Al-Kadri H; Gopala K; Kandeil W; Quint W; Al-Aker M; DeAntonio R
    BMC Infect Dis; 2014 Dec; 14():643. PubMed ID: 25496614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections.
    Rousseau MC; Franco EL; Villa LL; Sobrinho JP; Termini L; Prado JM; Rohan TE
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):469-76. PubMed ID: 10815691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection.
    Vriend HJ; Bogaards JA; van Bergen JE; Brink AA; van den Broek IV; Hoebe CJ; King AJ; van der Sande MA; Wolffs PF; de Melker HE;
    Cancer Med; 2015 Oct; 4(10):1589-98. PubMed ID: 26194784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women.
    Brown DR; Shew ML; Qadadri B; Neptune N; Vargas M; Tu W; Juliar BE; Breen TE; Fortenberry JD
    J Infect Dis; 2005 Jan; 191(2):182-92. PubMed ID: 15609227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus type-specific prevalence in women referred for colposcopic examination in Beijing.
    Ding X; Liu Z; Su J; Yan D; Sun W; Zeng Z
    J Med Virol; 2014 Nov; 86(11):1937-43. PubMed ID: 25132373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.